Common Stock, Shares, Issued of Qualigen Therapeutics, Inc. from Q4 2014 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Qualigen Therapeutics, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2014 to Q3 2025.
  • Qualigen Therapeutics, Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2025 was 3.06M shares, a 458% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)

Qualigen Therapeutics, Inc. Quarterly Common Stock, Shares, Issued (shares)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 3.06M +2.51M +458% Sep 30, 2025 10-Q 2025-11-14
Q2 2025 1.64M -7.98M -83% Jun 30, 2025 10-Q 2025-08-14
Q1 2025 1.63M -4.88M -75% Mar 31, 2025 10-Q 2025-07-21
Q4 2024 736K +629K +587% Dec 31, 2024 10-Q 2025-11-14
Q3 2024 548K -4.5M -89.1% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 9.61M +4.56M +90.3% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 6.5M +1.45M +28.7% Mar 31, 2024 10-Q 2024-07-02
Q4 2023 107K -4.1M -97.5% Dec 31, 2023 10-K 2025-06-30
Q3 2023 5.05M -37.1M -88% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 5.05M -33.7M -87% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 5.05M -30.2M -85.7% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 4.21M +682K +19.3% Dec 31, 2022 10-K 2024-04-08
Q3 2022 42.1M +13M +44.8% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 38.8M +9.89M +34.2% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 35.3M +6.46M +22.4% Mar 31, 2022 10-Q 2022-05-13
Q4 2021 3.53M -23.8M -87.1% Dec 31, 2021 10-K 2023-05-02
Q3 2021 29.1M Sep 30, 2021 10-Q 2021-11-15
Q2 2021 28.9M Jun 30, 2021 10-Q 2021-08-16
Q1 2021 28.8M -16.9M -36.9% Mar 31, 2021 10-Q 2021-05-14
Q4 2020 27.3M +8.19M +42.8% Dec 31, 2020 10-K 2022-03-31
Q1 2020 45.7M +36.7M +406% Mar 31, 2020 10-Q 2020-05-01
Q4 2019 19.1M +13.1M +217% Dec 31, 2019 10-Q 2020-05-01
Q3 2019 9.93M +4.19M +73.1% Sep 30, 2019 10-Q 2019-11-14
Q2 2019 9.04M +3.71M +69.5% Jun 30, 2019 10-Q 2019-08-14
Q1 2019 9.04M +4.02M +80.1% Mar 31, 2019 10-Q 2019-05-15
Q4 2018 6.04M +1.1M +22.2% Dec 31, 2018 10-K 2020-03-31
Q3 2018 5.73M -9.02M -61.1% Sep 30, 2018 10-Q 2018-11-09
Q2 2018 5.33M -9.42M -63.8% Jun 30, 2018 10-Q 2018-08-14
Q1 2018 5.02M -6.6M -56.8% Mar 31, 2018 10-Q 2018-05-15
Q4 2017 4.94M -6.68M -57.5% Dec 31, 2017 10-K 2019-04-01
Q3 2017 14.8M +6.16M +71.7% Sep 30, 2017 10-Q 2017-10-31
Q2 2017 14.8M +6.17M +71.9% Jun 30, 2017 10-Q 2017-08-07
Q1 2017 11.6M +3.03M +35.3% Mar 31, 2017 10-Q 2017-05-09
Q4 2016 11.6M +3.04M +35.4% Dec 31, 2016 10-K 2018-03-19
Q3 2016 8.59M +800K +10.3% Sep 30, 2016 10-Q 2016-11-07
Q2 2016 8.58M +797K +10.2% Jun 30, 2016 10-Q 2016-08-08
Q1 2016 8.58M Mar 31, 2016 10-Q 2016-05-09
Q4 2015 8.58M +8.12M +1744% Dec 31, 2015 10-K 2017-02-27
Q3 2015 7.79M Sep 30, 2015 10-Q 2015-11-10
Q2 2015 7.79M Jun 30, 2015 10-Q 2015-08-12
Q4 2014 465K Dec 31, 2014 10-K 2016-03-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.